Figure 4
From: Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
Incidence rates of all- cause mortality in patients with no exacerbations, patients ≥ 1 moderate exacerbation, and patients experiencing ≥ 1 severe exacerbation while on study treatment.